174 related articles for article (PubMed ID: 31374908)
1. Common variants at 9q22.33, 14q13.3, and ATM loci, and risk of differentiated thyroid cancer in the French Polynesian population.
Maillard S; Damiola F; Clero E; Pertesi M; Robinot N; Rachédi F; Boissin JL; Sebbag J; Shan L; Bost-Bezeaud F; Petitdidier P; Doyon F; Xhaard C; Rubino C; Blanché H; Drozdovitch V; Lesueur F; de Vathaire F
PLoS One; 2015; 10(4):e0123700. PubMed ID: 25849217
[TBL] [Abstract][Full Text] [Related]
2. Common variants at the 9q22.33, 14q13.3 and ATM loci, and risk of differentiated thyroid cancer in the Cuban population.
Pereda CM; Lesueur F; Pertesi M; Robinot N; Lence-Anta JJ; Turcios S; Velasco M; Chappe M; Infante I; Bustillo M; García A; Clero E; Xhaard C; Ren Y; Maillard S; Damiola F; Rubino C; Salazar S; Rodriguez R; Ortiz RM; de Vathaire F
BMC Genet; 2015 Mar; 16():22. PubMed ID: 25879635
[TBL] [Abstract][Full Text] [Related]
3. A comprehensive haplotype analysis of the XPC genomic sequence reveals a cluster of genetic variants associated with sensitivity to tobacco-smoke mutagens.
Rondelli CM; El-Zein RA; Wickliffe JK; Etzel CJ; Abdel-Rahman SZ
Toxicol Sci; 2010 May; 115(1):41-50. PubMed ID: 20106949
[TBL] [Abstract][Full Text] [Related]
4. Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.
Kulkarni O; Sugier PE; Guibon J; Boland-Augé A; Lonjou C; Bacq-Daian D; Olaso R; Rubino C; Souchard V; Rachedi F; Lence-Anta JJ; Ortiz RM; Xhaard C; Laurent-Puig P; Mulot C; Guizard AV; Schvartz C; Boutron-Ruault MC; Ostroumova E; Kesminiene A; Deleuze JF; Guénel P; De Vathaire F; Truong T; Lesueur F
Sci Rep; 2021 Apr; 11(1):8932. PubMed ID: 33903625
[TBL] [Abstract][Full Text] [Related]
5. Genetic susceptibility may modify the association between cell phone use and thyroid cancer: A population-based case-control study in Connecticut.
Luo J; Li H; Deziel NC; Huang H; Zhao N; Ma S; Ni X; Udelsman R; Zhang Y
Environ Res; 2020 Mar; 182():109013. PubMed ID: 31918310
[TBL] [Abstract][Full Text] [Related]
6. Genetic signature of differentiated thyroid carcinoma susceptibility: a machine learning approach.
Brigante G; Lazzaretti C; Paradiso E; Nuzzo F; Sitti M; Tüttelmann F; Moretti G; Silvestri R; Gemignani F; Försti A; Hemminki K; Elisei R; Romei C; Zizzi EA; Deriu MA; Simoni M; Landi S; Casarini L
Eur Thyroid J; 2022 Oct; 11(5):. PubMed ID: 35976137
[TBL] [Abstract][Full Text] [Related]
7. Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.
Guibon J; Sugier PE; Kulkarni O; Karimi M; Bacq-Daian D; Besse C; Boland A; Adjadj E; Rachédi F; Rubino C; Xhaard C; Mulot C; Laurent-Puig P; Guizard AV; Schvartz C; Ortiz RM; Ren Y; Ostroumova E; Deleuze JF; Boutron-Ruault MC; Kesminiene A; De Vathaire F; Guénel P; Lesueur F; Truong T
Oncotarget; 2021 Mar; 12(5):493-506. PubMed ID: 33747362
[TBL] [Abstract][Full Text] [Related]
8. Identification of crucial genes involved in thyroid cancer development.
Kalarani IB; Sivamani G; Veerabathiran R
J Egypt Natl Canc Inst; 2023 May; 35(1):15. PubMed ID: 37211566
[TBL] [Abstract][Full Text] [Related]
9. Immunomorphological Patterns of Chaperone System Components in Rare Thyroid Tumors with Promise as Biomarkers for Differential Diagnosis and Providing Clues on Molecular Mechanisms of Carcinogenesis.
Paladino L; Santonocito R; Graceffa G; Cipolla C; Pitruzzella A; Cabibi D; Cappello F; Conway de Macario E; Macario AJL; Bucchieri F; Rappa F
Cancers (Basel); 2023 Apr; 15(8):. PubMed ID: 37190332
[TBL] [Abstract][Full Text] [Related]
10. Variants in TPO rs2048722, PTCSC2 rs925489 and SEMA4G rs4919510 affect thyroid carcinoma susceptibility risk.
Shen Z; Sun Y; Niu G
BMC Med Genomics; 2023 Feb; 16(1):19. PubMed ID: 36737753
[TBL] [Abstract][Full Text] [Related]
11. Aberrant DNA repair as a potential contributor for the clonal evolution in subsets of anaplastic thyroid carcinomas arising through dedifferentiation: implications for future therapeutic algorithms?
Juhlin CC
Cancer Drug Resist; 2020; 3(4):992-1000. PubMed ID: 35582231
[TBL] [Abstract][Full Text] [Related]
12. Rare germline variants in DNA repair-related genes are accountable for papillary thyroid cancer susceptibility.
Mio C; Verrienti A; Pecce V; Sponziello M; Damante G
Endocrine; 2021 Sep; 73(3):648-657. PubMed ID: 33821390
[TBL] [Abstract][Full Text] [Related]
13. Micronuclei Formation upon Radioiodine Therapy for Well-Differentiated Thyroid Cancer: The Influence of DNA Repair Genes Variants.
S Santos L; M Gil O; N Silva S; C Gomes B; C Ferreira T; Limbert E; Rueff J
Genes (Basel); 2020 Sep; 11(9):. PubMed ID: 32957448
[TBL] [Abstract][Full Text] [Related]
14. Lack of Mutations in POT1 Gene in Selected Families with Familial Non-Medullary Thyroid Cancer.
Orois A; Badenas C; Reverter JL; López V; Potrony M; Mora M; Halperin I; Oriola J
Horm Cancer; 2020 Apr; 11(2):111-116. PubMed ID: 32172474
[TBL] [Abstract][Full Text] [Related]
15. Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes.
Santos LS; Gomes BC; Bastos HN; Gil OM; Azevedo AP; Ferreira TC; Limbert E; Silva SN; Rueff J
Genes (Basel); 2019 Aug; 10(8):. PubMed ID: 31374908
[TBL] [Abstract][Full Text] [Related]
16. The role of CCNH Val270Ala (rs2230641) and other nucleotide excision repair polymorphisms in individual susceptibility to well-differentiated thyroid cancer.
Santos LS; Gomes BC; Gouveia R; Silva SN; Azevedo AP; Camacho V; Manita I; Gil OM; Ferreira TC; Limbert E; Rueff J; Gaspar JF
Oncol Rep; 2013 Nov; 30(5):2458-66. PubMed ID: 23982724
[TBL] [Abstract][Full Text] [Related]
17. Association Studies Between XRCC1, XRCC2, XRCC3 Polymorphisms and Differentiated Thyroid Carcinoma.
Yan L; Li Q; Li X; Ji H; Zhang L
Cell Physiol Biochem; 2016; 38(3):1075-84. PubMed ID: 26938431
[TBL] [Abstract][Full Text] [Related]
18. Genetic variation in immune regulation and DNA repair pathways and stomach cancer in China.
Hussain SK; Mu LN; Cai L; Chang SC; Park SL; Oh SS; Wang Y; Goldstein BY; Ding BG; Jiang Q; Rao J; You NC; Yu SZ; Papp JC; Zhao JK; Wang H; Zhang ZF
Cancer Epidemiol Biomarkers Prev; 2009 Aug; 18(8):2304-9. PubMed ID: 19661089
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]